Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antimicrobial-Resistant Gram-Negative Bacteria (R01)

The summary for the Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antimicrobial-Resistant Gram-Negative Bacteria (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antimicrobial-Resistant Gram-Negative Bacteria (R01): The purpose of this Funding Opportunity Announcement (FOA) is to support milestone-driven projects focused on developing and utilizing novel predictive assays, models and/or research tools based on penetration and efflux of small molecules to facilitate therapeutic discovery for select Gram-negative bacterial pathogens: carbapenem-resistant Enterobacteriaceae (CRE), MDR Acinetobacter and/or MDR Pseudomonas aeruginosa.
Federal Grant Title: Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antimicrobial-Resistant Gram-Negative Bacteria (R01)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AI-16-081
Type of Funding: Grant
CFDA Numbers: 93.855, 93.856
CFDA Descriptions: Information not provided
Current Application Deadline: May 17th, 2017
Original Application Deadline: May 17th, 2017
Posted Date: November 16th, 2016
Creation Date: November 16th, 2016
Archive Date: June 17th, 2017
Total Program Funding: $9,000,000
Maximum Federal Grant Award: $1,050,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: November 16th, 2016
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-16-081.html
Grant Announcement Contact
NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
• Immune Tolerance Network (UM1 Clinical Trial Required)
• Accelerating Research and Development of Next Generation Vaccines against Malaria - a Mode...
• Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
• Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
• Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
• Center for HIV/AIDS Vaccine Immunology (CHAVI)
• Genomics of Transplantation Cooperative Research Program
• Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health
• Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...
• Immune Tolerance Network (UM1 Clinical Trial Required)
• Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...
• National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...
• Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Interven...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2026 FederalGrants.com